Next Article in Journal
A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
Next Article in Special Issue
Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52
Previous Article in Journal
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners
Previous Article in Special Issue
Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis
Erratum published on 19 March 2018, see Cancers 2018, 10(3), 79.
Open AccessEditor’s ChoiceEditorial

The Epithelial-to-Mesenchymal Transition in Cancer

Université de Poitiers, UMR-CNRS 7267, Laboratoire EBI, SEVE, F-86073 Poitiers, France
Cancers 2018, 10(2), 52; https://doi.org/10.3390/cancers10020052
Received: 11 February 2018 / Revised: 13 February 2018 / Accepted: 13 February 2018 / Published: 16 February 2018
(This article belongs to the Special Issue The Epithelial-to-Mesenchymal Transition (EMT) in Cancer)
Note: In lieu of an abstract, this is an excerpt from the first page.

The epithelial-to-mesenchymal transition (EMT) occurs during normal embryonic development, tissue regeneration, organ fibrosis, and wound healing.[...] View Full-Text
MDPI and ACS Style

Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers 2018, 10, 52.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop